Veranova: A CDMO that manages complexity with confidence.
01 1Macfarlan Smith Limited
02 1Veranova, L.P.
03 1Purisys LLC
04 1Arevipharma GmbH
05 1Indivior UK Limited
06 1Janssen Pharmaceutica NV
07 1Janssen Pharmaceutical Sciences Unlimited Company
08 1Medisca Inc
09 1Siegfried AG
10 1Siegfried PharmaChemikalien Minden Gmbh
11 1Siegfried USA, LLC
12 1SpecGx LLC
13 1TAPI Czech Industries s.r.o.
14 1Teva Czech Industries s.r.o
01 1BUPRENORPHINE BASE
02 12Buprenorphine
03 1Buprenorphine Base
01 1Germany
02 1Ireland
03 1Israel
04 3Switzerland
05 7U.S.A
06 1Blank
Veranova: A CDMO that manages complexity with confidence.
NDC Package Code : 12707-036
Start Marketing Date : 2017-12-11
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (100g/100g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 73548-1039
Start Marketing Date : 2020-07-14
End Marketing Date : 2025-07-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Veranova: A CDMO that manages complexity with confidence.
NDC Package Code : 49812-0239
Start Marketing Date : 1996-01-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 10920-593
Start Marketing Date : 2012-07-30
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 12578-607
Start Marketing Date : 2011-05-02
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 0406-3205
Start Marketing Date : 2011-12-17
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 38779-3255
Start Marketing Date : 2022-03-02
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 0792-0631
Start Marketing Date : 2015-02-27
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 17205-100
Start Marketing Date : 2010-01-27
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 47848-030
Start Marketing Date : 2014-02-10
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (100kg/100kg)
Marketing Category : BULK INGREDIENT
A Buprenorphine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Buprenorphine, including repackagers and relabelers. The FDA regulates Buprenorphine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Buprenorphine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Buprenorphine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Buprenorphine supplier is an individual or a company that provides Buprenorphine active pharmaceutical ingredient (API) or Buprenorphine finished formulations upon request. The Buprenorphine suppliers may include Buprenorphine API manufacturers, exporters, distributors and traders.
click here to find a list of Buprenorphine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Buprenorphine as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Buprenorphine API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Buprenorphine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Buprenorphine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Buprenorphine NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Buprenorphine suppliers with NDC on PharmaCompass.
We have 9 companies offering Buprenorphine
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
